{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/regulation-83",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/regulation-83.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "regulation/83",
  "kind": "regulation",
  "number": "83",
  "heading": "Procedure for suspensions in fitness cases",
  "text": "(1) Where NHS England is considering suspending an NHS chemist (C) from a pharmaceutical list under section 154(1) or section 155(2) of the 2006 Act (which relate to suspension and suspension pending appeal), before reaching its decision, it must—\n(a) notify C of the action NHS England is considering taking and its grounds for considering taking that action; and\n(b) as part of that notification—\n(i) where NHS England is considering taking action under section 154(1), inform C of any allegation against C, and\n(ii) advise C that C may make oral representations to NHS England with regard to the possible suspension on a specified day, provided C notifies NHS England of C's wish to do so within a specified period (of not less than 24 hours).\n(2) If, within the specified period—\n(a) C does not advise NHS England that C wishes to make oral representations to NHS England on the specified day, thereafter NHS England may suspend C with immediate effect; or\n(b) C does advise NHS England that C wishes to make oral representations to NHS England on the specified day, NHS England must not suspend C until after the oral hearing, but may then do so with immediate effect.\n(3) Once NHS England has taken its decision, it must notify C of its decision as soon as is practicable, and it must include with the notification of its decision an explanation of—\n(a) the reasons for the decision;\n(b) if NHS England has decided to suspend C under section 154(1), the arrangements for review of the suspension under section 157(1) of the 2006 Act (review of decisions).",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    },
    {
      "type": "M",
      "label": "M1",
      "text": "Section 154 has been amended by the Health and Social Care Act 2012 (c. 7) (“the 2012 Act”), Schedule 4, paragraph 81, and by S.I. 2010/22. Section 155 has been amended by the 2012 Act, Schedule 4, paragraph 82, and by S.I. 2010/22."
    },
    {
      "type": "M",
      "label": "M2",
      "text": "Section 157 has been amended by the Health and Social Care Act 2012, Schedule 4, paragraph 83, and by S.I. 2010/22."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/regulation/83",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}